Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Allogene Therapeutics Inc (ALLO)

Allogene Therapeutics Inc (ALLO)
1.6000 x 6 1.6300 x 5
Post-market by (Cboe BZX)
1.6000 -0.0800 (-4.76%) 03/25/25 [NASDAQ]
1.6000 x 6 1.6300 x 5
Post-market 1.6299 +0.0299 (+1.87%) 17:39 ET
Quote Overview for Tue, Mar 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.5900
Day High
1.7000
Open 1.6900
Previous Close 1.6800 1.6800
Volume 1,555,200 1,555,200
Avg Vol 3,598,930 3,598,930
Stochastic %K 13.08% 13.08%
Weighted Alpha -68.59 -68.59
5-Day Change -0.0900 (-5.33%) -0.0900 (-5.33%)
52-Week Range 1.3200 - 4.6300 1.3200 - 4.6300
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 365,005
  • Shares Outstanding, K 217,265
  • Annual Sales, $ 20 K
  • Annual Income, $ -257,590 K
  • EBIT $ -273 M
  • EBITDA $ -268 M
  • 60-Month Beta 1.02
  • Price/Sales 15,998.60
  • Price/Cash Flow N/A
  • Price/Book 0.80

Options Overview Details

View History
  • Implied Volatility 141.42% ( +26.02%)
  • Historical Volatility 167.18%
  • IV Percentile 74%
  • IV Rank 19.76%
  • IV High 678.39% on 05/17/24
  • IV Low 9.15% on 08/15/24
  • Put/Call Vol Ratio 0.08
  • Today's Volume 409
  • Volume Avg (30-Day) 352
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 5,513
  • Open Int (30-Day) 10,864

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.29
  • Number of Estimates 9
  • High Estimate -0.19
  • Low Estimate -0.39
  • Prior Year -0.38
  • Growth Rate Est. (year over year) +23.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5300 +4.58%
on 03/21/25
Period Open: 1.9850
2.3200 -31.03%
on 03/07/25
-0.3850 (-19.40%)
since 02/25/25
3-Month
1.3200 +21.21%
on 02/12/25
Period Open: 2.0900
3.7800 -57.67%
on 02/19/25
-0.4900 (-23.44%)
since 12/24/24
52-Week
1.3200 +21.21%
on 02/12/25
Period Open: 4.2900
4.6300 -65.44%
on 03/27/24
-2.6900 (-62.70%)
since 03/25/24

Most Recent Stories

More News
Allogene's Q4 Loss Narrower Than Expected, Revenues Nil

Allogene Therapeutics ALLO incurred a loss of 28 cents per share in fourth-quarter 2024, narrower than the Zacks Consensus Estimate of a loss of 34 cents. In the year-ago period, the company had incurred...

ALLO : 1.6000 (-4.76%)
CTMX : 0.6151 (-8.17%)
ETNB : 8.01 (-12.46%)
ANIP : 66.33 (+0.53%)
Allogene Therapeutics: Q4 Earnings Snapshot

Allogene Therapeutics: Q4 Earnings Snapshot

ALLO : 1.6000 (-4.76%)
Allogene Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update

ALLO : 1.6000 (-4.76%)
From Clinical Trials to the Market: Cancer Stocks With Big Potential in 2025

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – As cancer rates continue to climb worldwide, the push for innovative treatments has never been more...

ALLO : 1.6000 (-4.76%)
ONCY : 0.6347 (+0.86%)
TARA : 4.73 (+0.64%)
YMAB : 5.09 (-1.36%)
FATE : 0.9027 (-4.05%)
ONC.TO : 0.91 (+2.25%)
Allogene Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update

ALLO : 1.6000 (-4.76%)
Allogene Therapeutics Announces Participation in March Investor Conference

ALLO : 1.6000 (-4.76%)
Allogene Therapeutics Expands Strategic Partnership with Foresight Diagnostics to Advance Joint Development Activities Outside the US Across Europe, UK, Canada, and Australia

ALLO : 1.6000 (-4.76%)
Allogene Short Interest Reportedly Near 5-Year Lows Amid Growing Retail Optimism: Analyst Sees CAR-T Therapy Promise

Baird remains bullish on Allogene, stating that the updated cema-cel data continues to support the "differentiated durability" of its allogeneic CAR-T therapy.

ALLO : 1.6000 (-4.76%)
PFE : 25.55 (-2.26%)
Optimism in War on Cancer on the Rise, as Biotech Companies Roll Out More Wins

Vancouver, BC – February 18, 2025 – USA News Group News Commentary – Despite optimism coming from the launch of Project Stargate (a $500 billion investment in AI data centers), there is still cause...

ONCY : 0.6347 (+0.86%)
ALLO : 1.6000 (-4.76%)
VRCA : 0.4767 (-8.70%)
ONC.TO : 0.91 (+2.25%)
OSTX : 1.5900 (-5.36%)
IBRX : 2.74 (-3.86%)
Optimism in War on Cancer on the Rise, as Biotech Companies Roll Out More Wins

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Despite optimism coming from the launch of Project Stargate (a $500 billion investment in AI data centers),...

ALLO : 1.6000 (-4.76%)
ONCY : 0.6347 (+0.86%)
VRCA : 0.4767 (-8.70%)
ONC.TO : 0.91 (+2.25%)
IBRX : 2.74 (-3.86%)
OSTX : 1.5900 (-5.36%)

Business Summary

Allogene Therapeutics, Inc. is a clinical-stage immuno-oncology company, primarily focused on the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer.'

See More

Key Turning Points

3rd Resistance Point 1.7800
2nd Resistance Point 1.7400
1st Resistance Point 1.6700
Last Price 1.6000
1st Support Level 1.5600
2nd Support Level 1.5200
3rd Support Level 1.4500

See More

52-Week High 4.6300
Fibonacci 61.8% 3.3656
Fibonacci 50% 2.9750
Fibonacci 38.2% 2.5844
Last Price 1.6000
52-Week Low 1.3200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals